Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Clinical impact of primary tumor sidedness and sex on unresectable post-recurrence survival in resected pathological stage II-III colorectal cancers: a nationwide multicenter retrospective study

Fig. 1

Study cohort selection process. The Japanese Study Group for Follow-Up of Colorectal Cancer collected clinicopathological data from 22,638 patients with pathological stage II-III colorectal cancer who underwent radical surgery between January 2004 and December 2012 at 24 Japanese referral hospitals. A total of 964 patients with unresectable recurrent colorectal cancer treated with chemotherapy were included in the final study population. Patients treated with palliative chemotherapy were excluded

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us